...
首页> 外文期刊>Molecular cell >Identity between TRAP and SMCC Complexes Indicates Novel Pathways for the Function of Nuclear Receptors and Diverse Mammalian Activators
【24h】

Identity between TRAP and SMCC Complexes Indicates Novel Pathways for the Function of Nuclear Receptors and Diverse Mammalian Activators

机译:TRAP和SMCC复合物之间的同一性表明核受体和各种哺乳动物激活子功能的新途径。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The human thyroid hormone receptor-associated protein (TRAP) complex, an earlier described coactivator for nuclear receptors, and an SRB- and MED-containing cofactor complex (SMCC) that mediates activation by Gal4-p53 are shown to be virtually the same with respect to specific polypeptide subunits, coactivator functions, and mechanisms of action (activator interactions). In parallel with ligand-dependent interactions of nuclear receptors with the TRAP220 subunit, p53 and VP16 activation domains interact directly with a newly cloned TRAP80 subunit. These results indicate novel pathways for the function of nuclear receptors and other activators (p53 and VP16) through a common coactivator complex that is likely to target RNA polymerase II. Identification of the TRAP230 subunit as a previously predicted gene product also suggests a coactivator-related transcription defect in certain disease states.
机译:人类甲状腺激素受体相关蛋白(TRAP)复合物,较早描述的核受体共激活物以及介导Gal4-p53激活的含SRB和MED的辅因子复合物(SMCC)实际上在方面是相同的特定的多肽亚基,共激活因子功能和作用机制(激活因子相互作用)。与核受体与TRAP220亚基的配体依赖性相互作用同时,p53和VP16激活域直接与新克隆的TRAP80亚基相互作用。这些结果表明,通过可能靶向RNA聚合酶II的常见共激活物复合物,核受体和其他激活物(p53和VP16)功能的新途径。将TRAP230亚基鉴定为先前预测的基因产物,也表明在某些疾病状态下与共激活因子相关的转录缺陷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号